T. Rowe Price Associates’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-17,700
| Closed | -$159K | – | 2612 |
|
|
2016
Q3 | $159K | Sell |
17,700
-24,600
| -58% | -$221K | ﹤0.01% | 2382 |
|
|
2016
Q2 | $227K | Hold |
42,300
| – | – | ﹤0.01% | 2278 |
|
|
2016
Q1 | $195K | Buy |
42,300
+19,400
| +85% | +$89.4K | ﹤0.01% | 2296 |
|
|
2015
Q4 | $119K | Sell |
22,900
-10,700
| -32% | -$55.6K | ﹤0.01% | 2398 |
|
|
2015
Q3 | $203K | Sell |
33,600
-6,600
| -16% | -$39.9K | ﹤0.01% | 2287 |
|
|
2015
Q2 | $635K | Buy |
40,200
+6,800
| +20% | +$107K | ﹤0.01% | 1898 |
|
|
2015
Q1 | $363K | Buy |
33,400
+6,400
| +24% | +$69.6K | ﹤0.01% | 2104 |
|
|
2014
Q4 | $284K | Hold |
27,000
| – | – | ﹤0.01% | 2200 |
|
|
2014
Q3 | $259K | Hold |
27,000
| – | – | ﹤0.01% | 2216 |
|
|
2014
Q2 | $312K | Sell |
27,000
-4,500
| -14% | -$52K | ﹤0.01% | 2163 |
|
|
2014
Q1 | $315K | Buy |
31,500
+8,400
| +36% | +$84K | ﹤0.01% | 2134 |
|
|
2013
Q4 | $301K | Buy |
+23,100
| New | +$301K | ﹤0.01% | 2139 |
|